Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma
Trial ID or NCT#
Status
Purpose
To determine the efficacy and toxicity of TACE combined with SBRT
Official Title
Phase II Study of Combination Stereotactic Body Radiotherapy (SBRT) With Transarterial Chemo-Embolization (TACE) for Unresectable Hepatocellular Carcinoma
Eligibility Criteria
Investigator(s)
Contact us to find out if this trial is right for you.
Contact
ccto-office@stanford.edu
650-498-7061
View on ClinicalTrials.gov